Search Results - "GREGORY, JUSTIN M." :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic's Impact in Type 1 and Type 2 Diabetes

COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic's Impact in Type 1 and Type 2 Diabetes

by Gregory, Justin M, Slaughter, James C, Duffus, Sara H, Smith, T Jordan, LeStourgeon, Lauren M, Jaser, Sarah S, McCoy, Allison B, Luther, James M, Giovannetti, Erin R, Boeder, Schafer, Pettus, Jeremy H, Moore, Daniel J
Published in Diabetes care (01.02.2021)

Get full text

Journal Article

A high-fat and fructose diet in dogs mirrors insulin resistance and β-cell dysfunction characteristic of impaired glucose tolerance in humans

A high-fat and fructose diet in dogs mirrors insulin resistance and β-cell dysfunction characteristic of impaired glucose tolerance in humans

by Gregory, Justin M, Kraft, Guillaume, Dalla Man, Chiara, Slaughter, James C, Scott, Melanie F, Hastings, Jon R, Edgerton, Dale S, Moore, Mary C, Cherrington, Alan D
Published in PloS one (01.12.2023)

Get full text

Journal Article

The Peripheral Peril: Injected Insulin Induces Insulin Insensitivity in Type 1 Diabetes

The Peripheral Peril: Injected Insulin Induces Insulin Insensitivity in Type 1 Diabetes

by Gregory, Justin M, Cherrington, Alan D, Moore, Daniel J
Published in Diabetes (New York, N.Y.) (01.05.2020)

Get full text

Journal Article

The Dual Burden of Type 1 Diabetes and COVID-19

The Dual Burden of Type 1 Diabetes and COVID-19

by Gregory, Justin M, Moore, Daniel J
Published in Annals of Internal Medicine (01.05.2021)

Get full text

Journal Article Web Resource

Letter to the Editor From Gregory and Moore: "Age and Hospitalization Risk in People With Type 1 Diabetes and COVID-19: Data From the T1D Exchange Surveillance Study"

Letter to the Editor From Gregory and Moore: "Age and Hospitalization Risk in People With Type 1 Diabetes and COVID-19: Data From the T1D Exchange Surveillance Study"

by Gregory, Justin M, Moore, Daniel J
Published in The journal of clinical endocrinology and metabolism (24.03.2022)

Get full text

Journal Article

Mitigating micro-and macro-vascular complications of diabetes beginning in adolescence

Mitigating micro-and macro-vascular complications of diabetes beginning in adolescence

by Moore, Daniel J, Gregory, Justin M, Kumah-Crystal, Yaa A, Simmons, Jill H
Published in Vascular health and risk management (01.01.2009)

Get full text

Journal Article

Increased proportion of time in hybrid closed‐loop “Auto Mode” is associated with improved glycaemic control for adolescent and young patients with adult type 1 diabetes using the MiniMed 670G insulin pump

Increased proportion of time in hybrid closed‐loop “Auto Mode” is associated with improved glycaemic control for adolescent and young patients with adult type 1 diabetes using the MiniMed 670G insulin pump

by Duffus, Sara H., Ta'ani, Zain Al, Slaughter, James C., Niswender, Kevin D., Gregory, Justin M
Published in Diabetes, obesity & metabolism (01.04.2020)

Get full text

Journal Article

148-OR: CGM Time Below Range Predicts Epinephrine Response to Hypoglycemia in Patients with Type 1 Diabetes

148-OR: CGM Time Below Range Predicts Epinephrine Response to Hypoglycemia in Patients with Type 1 Diabetes

by THOMAS, ROBERT L., GREGORY, JUSTIN M., GIOVANNETTI, ERIN R., BOEDER, SCHAFER C., PETTUS, JEREMY
Published in Diabetes (New York, N.Y.) (20.06.2023)

Get full text

Journal Article

Importance of the route of insulin delivery to its control of glucose metabolism

Importance of the route of insulin delivery to its control of glucose metabolism

by Edgerton, Dale S, Moore, Mary C, Gregory, Justin M, Kraft, Guillaume, Cherrington, Alan D
Published in American journal of physiology: endocrinology and metabolism (01.05.2021)

Get full text

Journal Article

SGLT2 Inhibition Increases Fasting Glucagon but Does Not Restore the Counterregulatory Hormone Response to Hypoglycemia in Participants With Type 1 Diabetes

SGLT2 Inhibition Increases Fasting Glucagon but Does Not Restore the Counterregulatory Hormone Response to Hypoglycemia in Participants With Type 1 Diabetes

by Boeder, Schafer C, Gregory, Justin M, Giovannetti, Erin R, Pettus, Jeremy H
Published in Diabetes (New York, N.Y.) (01.03.2022)

Get full text

Journal Article

Combination SGLT2 Inhibitor and Glucagon Receptor Antagonist Therapy in Type 1 Diabetes: A Randomized Clinical Trial

Combination SGLT2 Inhibitor and Glucagon Receptor Antagonist Therapy in Type 1 Diabetes: A Randomized Clinical Trial

by Boeder, Schafer C, Thomas, Robert L, Le Roux, Melissa J, Giovannetti, Erin R, Gregory, Justin M, Pettus, Jeremy H
Published in Diabetes care (22.05.2024)

Get full text

Journal Article

Continuous Glucose Monitoring Time Below Range Predicts Impaired Epinephrine Response to Hypoglycemia in Patients With Type 1 Diabetes

Continuous Glucose Monitoring Time Below Range Predicts Impaired Epinephrine Response to Hypoglycemia in Patients With Type 1 Diabetes

by Thomas, Robert L, Boeder, Schafer C, Hamidi, Vala, Giovannetti, Erin R, Gregory, Justin M, Pettus, Jeremy H
Published in Diabetes care (01.05.2024)

Get full text

Journal Article

COVID-19 Exacerbates Insulin Resistance During Diabetic Ketoacidosis in Pediatric Patients With Type 1 Diabetes

COVID-19 Exacerbates Insulin Resistance During Diabetic Ketoacidosis in Pediatric Patients With Type 1 Diabetes

by Keiner, Elizabeth S, Slaughter, James C, Datye, Karishma A, Cherrington, Alan D, Moore, Daniel J, Gregory, Justin M
Published in Diabetes care (01.10.2022)

Get full text

Journal Article

Reliability of Handheld Blood Glucose Monitors in Neonates: Trustworthy Arterial Readings but Capillary Results Warrant Caution for Hypoglycemia

Reliability of Handheld Blood Glucose Monitors in Neonates: Trustworthy Arterial Readings but Capillary Results Warrant Caution for Hypoglycemia

by Brooks, David, Slaughter, James C, Nichols, James H, Gregory, Justin M
Published in Journal of diabetes science and technology (20.10.2023)

Get full text

Journal Article

267-OR: ADA Presidents' Select Abstract: Combining an SGLT Inhibitor with a Glucagon Receptor Agonist (GRA) in Subjects with Type 1 Diabetes—A Randomized Clinical Trial

267-OR: ADA Presidents' Select Abstract: Combining an SGLT Inhibitor with a Glucagon Receptor Agonist (GRA) in Subjects with Type 1 Diabetes—A Randomized Clinical Trial

by BOEDER, SCHAFER C., ROUX, MELISSA J. LE, GIOVANNETTI, ERIN R., ARMSTRONG, ADRIENNE, CARTER, LESLIE, THOMAS, ROBERT L., GREGORY, JUSTIN M., PETTUS, JEREMY
Published in Diabetes (New York, N.Y.) (20.06.2023)

Get full text

Journal Article

Iatrogenic Hyperinsulinemia, Not Hyperglycemia, Drives Insulin Resistance in Type 1 Diabetes as Revealed by Comparison With GCK-MODY (MODY2)

Iatrogenic Hyperinsulinemia, Not Hyperglycemia, Drives Insulin Resistance in Type 1 Diabetes as Revealed by Comparison With GCK-MODY (MODY2)

by Gregory, Justin M, Smith, T Jordan, Slaughter, James C, Mason, Holly R, Hughey, Curtis C, Smith, Marta S, Kandasamy, Balamurugan, Greeley, Siri Atma W, Philipson, Louis H, Naylor, Rochelle N, Letourneau, Lisa R, Abumrad, Naji N, Cherrington, Alan D, Moore, Daniel J
Published in Diabetes (New York, N.Y.) (01.08.2019)

Get full text

Journal Article

Impact of Acipimox Therapy on Free Fatty Acid Efflux and Endothelial Function in the Metabolic Syndrome: A Randomized Trial

Impact of Acipimox Therapy on Free Fatty Acid Efflux and Endothelial Function in the Metabolic Syndrome: A Randomized Trial

by Aday, Aaron W., Goldfine, Allison B., Gregory, Justin M., Beckman, Joshua A.
Published in Obesity (Silver Spring, Md.) (01.11.2019)

Get full text

Journal Article

Can technological solutions for diabetes replace islet cell function?

Can technological solutions for diabetes replace islet cell function?

by Gregory, Justin M., Moore, Daniel J.
Published in Organogenesis (01.01.2011)

Get full text

Journal Article

A randomized pharmacokinetic and pharmacodynamic trial of two regular human insulins demonstrates bioequivalence in type 1 diabetes and availability of biosimilar insulin may improve access to this medication

A randomized pharmacokinetic and pharmacodynamic trial of two regular human insulins demonstrates bioequivalence in type 1 diabetes and availability of biosimilar insulin may improve access to this medication

by Vencio, Sérgio, Caiado‐Vencio, Rafael, Caixeta, Leonardo Ferreira, Masierek, Małgorzata, Mlynarski, Wojciech, Drzewoski, Józef, Gregory, Justin M.
Published in Diabetes, obesity & metabolism (01.08.2022)

Get full text

Journal Article

Fibrotic Encapsulation Is the Dominant Source of Continuous Glucose Monitor Delays

Fibrotic Encapsulation Is the Dominant Source of Continuous Glucose Monitor Delays

by McClatchey, P Mason, McClain, Ethan S, Williams, Ian M, Malabanan, Carlo M, James, Freyja D, Lord, Peter C, Gregory, Justin M, Cliffel, David E, Wasserman, David H
Published in Diabetes (New York, N.Y.) (01.10.2019)

Get full text

Journal Article